1-18 of 18
Authors: Michael Højby Rasmussen
Journal Article
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 12, December 2023, Pages 3090–3099, https://doi.org/10.1210/clinem/dgad394
Published: 05 July 2023
Journal Article
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3 Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 10, October 2023, Pages 2569–2578, https://doi.org/10.1210/clinem/dgad183
Published: 30 March 2023
Journal Article
Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial” Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 8, August 2023, Pages e647–e648, https://doi.org/10.1210/clinem/dgad095
Published: 03 March 2023
Journal Article
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 12, December 2022, Pages 3378–3388, https://doi.org/10.1210/clinem/dgac513
Published: 05 September 2022
Journal Article
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3 Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 5, May 2022, Pages 1357–1367, https://doi.org/10.1210/clinem/dgab928
Published: 29 December 2021
Journal Article
Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial” Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 2, February 2022, Pages e888–e889, https://doi.org/10.1210/clinem/dgab736
Published: 09 October 2021
Journal Article
Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 2, February 2021, Pages 567–576, https://doi.org/10.1210/clinem/dgaa775
Published: 12 December 2020
Journal Article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 4, April 2020, Pages e1358–e1376, https://doi.org/10.1210/clinem/dgaa049
Published: 05 February 2020
Journal Article
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 4, April 2020, Pages e1847–e1861, https://doi.org/10.1210/clinem/dgz310
Published: 09 January 2020
Journal Article
Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency Free
The Journal of Clinical Endocrinology & Metabolism, Volume 101, Issue 3, 1 March 2016, Pages 988–998, https://doi.org/10.1210/jc.2015-1991
Published: 01 March 2016
Journal Article
A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 10, 1 October 2014, Pages E1819–E1829, https://doi.org/10.1210/jc.2014-1702
Published: 01 October 2014
Journal Article
Assessing the Impact of Growth Hormone Deficiency and Treatment in Adults: Development of a New Disease-Specific Measure Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 4, 1 April 2014, Pages 1204–1212, https://doi.org/10.1210/jc.2013-3438
Published: 01 April 2014
Journal Article
Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 3, 1 March 2011, Pages 681–688, https://doi.org/10.1210/jc.2010-1931
Published: 01 March 2011
Journal Article
Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 95, Issue 7, 1 July 2010, Pages 3411–3417, https://doi.org/10.1210/jc.2009-2813
Published: 01 July 2010
Journal Article
Acute Growth Hormone Administration Causes Exaggerated Increases in Plasma Lactate and Glycerol during Moderate to High Intensity Bicycling in Trained Young Men Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 87, Issue 11, 1 November 2002, Pages 4966–4975, https://doi.org/10.1210/jc.2001-011797
Published: 01 November 2002
Journal Article
Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 87, Issue 10, 1 October 2002, Pages 4691–4698, https://doi.org/10.1210/jc.2002-020563
Published: 01 October 2002
Journal Article
GH Administration Changes Myosin Heavy Chain Isoforms in Skeletal Muscle But Does Not Augment Muscle Strength or Hypertrophy, Either Alone or Combined with Resistance Exercise Training in Healthy Elderly Men Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 87, Issue 2, 1 February 2002, Pages 513–523, https://doi.org/10.1210/jcem.87.2.8206
Published: 01 February 2002
Journal Article
The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor Binding Protein Complex in Serum: Hepatosplanchnic Release, Diurnal Variation, Circulating Concentrations in Healthy Subjects, and Diagnostic Use in Patients with Growth Hormone Deficiency Get access
The Journal of Clinical Endocrinology & Metabolism, Volume 83, Issue 12, 1 December 1998, Pages 4408–4415, https://doi.org/10.1210/jcem.83.12.5311
Published: 01 December 1998
